Northern Trust Company of Connecticut’s Abiomed Inc ABMD Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$153K	Buy	+5,732	New	+$142K	﹤0.01%	1828

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's ABMD Position: Q4 2013 in Review

Northern Trust Company of Connecticut opened a new position in Abiomed Inc (ABMD) in Q4 2013: 5,732 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #1828 among its holdings.

126 funds tracked by Wall St. Rank hold ABMD as of Q4 2013.

Northern Trust Company of Connecticut held 5,732 shares of Abiomed Inc worth $153K as of Q4 2013.
Abiomed Inc was a new Northern Trust Company of Connecticut position in Q4 2013.
Abiomed Inc made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1828 holding.
126 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.